Common use of Compliance with Nasdaq Continued Listing Requirements Clause in Contracts

Compliance with Nasdaq Continued Listing Requirements. Except as described in Schedule 3.20, the Company is in compliance with applicable Nasdaq continued listing requirements. Except as described in Schedule 3.20, there are no proceedings pending or, to the Company's Knowledge, threatened against the Company relating to the continued listing of the Company's Common Stock on Nasdaq and the Company has not received any notice of, nor to the Company's Knowledge is there any basis for, the delisting of the Common Stock from Nasdaq. Except as described in Schedule 3.20, the Company is in material compliance with NASD rules and regulations applicable to the Company.

Appears in 1 contract

Samples: Stock Purchase Agreement (Velocity Express Corp)

AutoNDA by SimpleDocs

Compliance with Nasdaq Continued Listing Requirements. Except as described in Schedule 3.20, the The Company is in compliance with applicable Nasdaq continued listing requirements, except as set out in Schedule 4.20. Except as described set out in Schedule 3.204.20, there are no proceedings pending or, to the Company's ’s Knowledge, threatened against the Company relating to the continued listing of the Company's ’s Common Stock on the Nasdaq and the Company has not received any notice of, nor to the Company's ’s Knowledge is there any basis for, the delisting of the Common Stock from the Nasdaq. Except as described in Schedule 3.20, the Company is in material compliance with NASD rules and regulations applicable to the Company.

Appears in 1 contract

Samples: Form of Purchase Agreement (World Heart Corp)

Compliance with Nasdaq Continued Listing Requirements. Except as described in Schedule 3.204.20, the Company is in compliance with applicable Nasdaq continued listing requirements. Except as described in Schedule 3.204.20, there are no proceedings pending or, to the Company's ’s Knowledge, threatened against the Company relating to the continued listing of the Company's Common Stock on Nasdaq and the Company has not received any notice of, nor to the Company's ’s Knowledge is there any basis for, the delisting of the Common Stock from Nasdaq. Except as described in Schedule 3.20, the Company is in material compliance with NASD rules and regulations applicable to the Company.

Appears in 1 contract

Samples: Purchase Agreement (Tapestry Pharmaceuticals, Inc)

Compliance with Nasdaq Continued Listing Requirements. Except as described in Schedule 3.204.20, the Company is in compliance with applicable Nasdaq continued listing requirements. Except as described in Schedule 3.204.20, there are no proceedings pending or, to the Company's ’s Knowledge, threatened against the Company relating to the continued listing of the Company's ’s Common Stock on Nasdaq and except as described in Schedule 4.20, the Company has not received any notice of, nor to the Company's ’s Knowledge is there any basis for, the delisting of the Common Stock from Nasdaq. Except as described in Schedule 3.20, the Company is in material compliance with NASD rules and regulations applicable to the Company.

Appears in 1 contract

Samples: Purchase Agreement (First Virtual Communications Inc)

AutoNDA by SimpleDocs

Compliance with Nasdaq Continued Listing Requirements. Except as described in Schedule 3.204.20, the Company is in compliance with applicable Nasdaq continued listing requirements. Except as described in Schedule 3.204.20, there are no proceedings pending or, to the Company's ’s Knowledge, threatened against the Company relating to the continued listing of the Company's ’s Common Stock on Nasdaq and the Company has not received any notice of, nor to the Company's ’s Knowledge is there any basis for, the delisting of the Common Stock from Nasdaq. Except as described in Schedule 3.204.20, the Company is in material compliance with NASD rules and regulations applicable to the Company.

Appears in 1 contract

Samples: Purchase Agreement (Velocity Express Corp)

Compliance with Nasdaq Continued Listing Requirements. Except as described in the SEC Filings or in Schedule 3.204.20, the Company is in compliance with applicable Nasdaq continued listing requirements. Except as described in the SEC Filings or in Schedule 3.204.20, there are no proceedings pending or, to the Company's ’s Knowledge, threatened against the Company relating to the continued listing of the Company's Common Stock on Nasdaq and the Company has not received any notice of, nor to the Company's ’s Knowledge is there any basis for, the delisting of the Common Stock from Nasdaq. Except as described in Schedule 3.20, the Company is in material compliance with NASD rules and regulations applicable to the Company.

Appears in 1 contract

Samples: Purchase Agreement (Cellegy Pharmaceuticals Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.